Versant Vantage II, L.P.

CIK 0001832235

10% Owner

Filings

Latest Oct 2, 2025

Issuers covered

Showing

14 of 14

Page 1

Track record

36 of 40 open-market trades scored (90% price coverage) - 4 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	36	36%	+2.8%	-3.4%	+34.6%	-44.2%
90 days	36	81%	+25.7%	+30.4%	+64.5%	-41.9%
180 days	36	100%	+63.2%	+69.2%	+82.2%	+4.9%
365 days	2	100%	+43.5%	+43.5%	+57.7%	+29.2%

Issuers

Companies where Versant Vantage II, L.P. has filed

Ticker	Issuer	Filings	Last filed
GRPH	Graphite Bio, Inc.	9	Oct 2, 2025
TPST	Tempest Therapeutics, Inc.	2	Aug 12, 2024
TSBX	Turnstone Biologics Corp.	2	Aug 12, 2025
IPSC	Century Therapeutics, Inc.	1	Feb 2, 2022

All filings

14 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Oct 2, 2025	GRPHGraphite Bio, Inc.	SSale	83,066	$46.4068	$3,854,827
Sep 22, 2025	GRPHGraphite Bio, Inc.	SSale	49,479	$41.5908	$2,057,871
Aug 26, 2025	GRPHGraphite Bio, Inc.	SSale	50,270	$39.5255	$1,986,947
Aug 19, 2025	GRPHGraphite Bio, Inc.	SSale	145,051	$39.50	$5,729,515
Aug 12, 2025	TSBXTurnstone Biologics Corp.	UTender	2,726,322	-	-
Jul 14, 2025	GRPHGraphite Bio, Inc.	SSale	191,376	$34.00	$6,506,784
Jul 1, 2025	GRPHGraphite Bio, Inc.	SSale	200,000	$30.465	$6,093,000
Jun 20, 2025	GRPHGraphite Bio, Inc.	SSale	133,924	$30.25	$4,051,201
Jun 12, 2025	GRPHGraphite Bio, Inc.	SSale	350,000	$29.00	$10,150,000
Aug 12, 2024	TPSTTempest Therapeutics, Inc.	SSale	400,000	$1.3501	$540,040
Mar 25, 2024	GRPHGraphite Bio, Inc.	JOther	598,203	-	-
Jul 27, 2023	TSBXTurnstone Biologics Corp.	PPurchase	197,458	$12.00	$2,369,496
May 3, 2022	TPSTTempest Therapeutics, Inc.	Holdings only	-	-	-
Feb 2, 2022	IPSCCentury Therapeutics, Inc.	JOther	178,996	$0.00	$0

Showing 1-14 of 14

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value